Zacks Investment Research upgraded shares of AMEDISYS INC (AMED) from NEUTRAL to OUTPERFORM on October 09, 2012, with a target price of $16.10.
Amedisys, Inc. is a leading multi-regional provider of home health care nursing services. They operate home care nursing offices in southern and southeastern United States.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on AMEDISYS INC (AMED),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment